These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11372445)

  • 1. [Pharmacokinetics of sodium bimetrondazole glycinate in mice and rats].
    Liu CX; Wei GL; Xiao SH
    Yao Xue Xue Bao; 2000 Oct; 35(10):770-3. PubMed ID: 11372445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of epristeride in rats and beagle dogs].
    Wei GL; Xiao SH; Liu CX
    Yao Xue Xue Bao; 2000 Oct; 35(10):721-4. PubMed ID: 11372434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution and metabolism of calcium [3H]metronidazolamate in mice].
    Zheng XL; Zhao F; Meng XS; Yang LX; Gao JG
    Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):561-4. PubMed ID: 2641858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic profile of naftopidil in rats].
    Yu D; Wan L; Lou Y
    Yao Xue Xue Bao; 1998 May; 33(5):335-8. PubMed ID: 12016999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacokinetics of 2-methyl-4-nitroimidazole-1-ethanol (isometronidazole) in man].
    Siegmund W; Zschiesche M; Franke G; Peters R; Brachmann O; Scherber A
    Pharmazie; 1988 Aug; 43(8):546-8. PubMed ID: 3237745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of a novel anti-tumor agent, beta-elemene, in Sprague-Dawley rats.
    Wang K; Li Z; Chen Y; Su C
    Biopharm Drug Dispos; 2005 Oct; 26(7):301-7. PubMed ID: 16041842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and skin blister fluid concentrations of metronidazole and its hydroxy metabolite after oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Pol J Pharmacol; 1996; 48(1):47-52. PubMed ID: 9112627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
    Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tissue distribution and excretion of bromotetrandrine in rats].
    Xiao SH; Wei GL; Lu R; Liu CX; Wang FP
    Yao Xue Xue Bao; 2005 May; 40(5):453-6. PubMed ID: 16220792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
    Zhong DF; Li K; Xu JH; Du Y; Zhang YF
    Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole.
    Rajnarayana K; Reddy MS; Vidyasagar J; Krishna DR
    Arzneimittelforschung; 2004; 54(2):109-13. PubMed ID: 15038460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs.
    Chu D; Liu W; Huang Z; Liu S; Fu X; Liu K
    Planta Med; 2006 Apr; 72(5):418-23. PubMed ID: 16557455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and bioavailability of clinafloxacin in rats].
    Zhou MH; Yu YQ; Duan GL; Cheng WB; Xu CJ; Liu X
    Yao Xue Xue Bao; 2001 Feb; 36(2):134-6. PubMed ID: 12579882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Zhou S; Kestell P; Tingle MD; Paxton JW
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.